What is Avanos Medical's D&A?

Avanos Medical (AVNS) reported D&A of $10.2M in Q1 2026.

How has Avanos Medical's D&A changed year-over-year?

Avanos Medical's D&A increased by 6.3% year-over-year, from $9.6M to $10.2M.

What is the long-term trend for Avanos Medical's D&A?

Over 4 years (2021 to 2025), Avanos Medical's D&A has grown at a 0.4% compound annual growth rate (CAGR), from $38.3M to $38.9M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Avanos Medical AVNS D&A

D&A at other companies

Cardinal HealthCAH

$248M+19.8%

Boston ScientificBSX

$351M+8.0%

Pacira BioSciences, Inc.PCRX

$21.33M+0.8%

MedtronicMDT

$716M-14.8%

Collegium Pharmaceutical, Inc.COLL

$463K-57.6%

IAR

Integra LifeSciencesIART

$38.43M+3.3%

Other financials

Income statement

See full

Revenue$182.2M+8.8%

Gross profit$94.2M+4.9%

Operating income$8.9M-13.6%

Net income$5.1M-22.7%

EPS (diluted)$0.11-21.4%

Balance sheet

See full

Cash & equivalents$65.6M-32.4%

Total debt$138.4M-1.8%

Total equity$782.1M-6.8%

Total assets$1.1B-5.2%

Cash flow

See full

Operating cash flow-$12.3M-148%

CapEx$4.3M-35.8%

Free cash flow-$16.6M-187%

Valuation

See full

Market cap$1.17B-1.2%

Enterprise value$1.24B+3.0%

P/S1.6×-0.1×

Profitability

See full

Gross margin50%-4.6pp

Operating margin-9.1%-4.2pp

Net margin-10.4%-4.7pp

FCF margin1.6%-14.9pp

Returns & leverage

See full

Return on equity-9.2%-3.9pp

Debt / equity0.2×0.0×

Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's D&A?: Avanos Medical (AVNS) reported D&A of $10.2M in Q1 2026.
How has Avanos Medical's D&A changed year-over-year?: Avanos Medical's D&A increased by 6.3% year-over-year, from $9.6M to $10.2M.
What is the long-term trend for Avanos Medical's D&A?: Over 4 years (2021 to 2025), Avanos Medical's D&A has grown at a 0.4% compound annual growth rate (CAGR), from $38.3M to $38.9M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.